News & Highlights

[Vox.com] The fiercest debate in health care is about a $1,000 pill

May 28, 2014

“The people who pay for drugs aren’t fully buying those arguments — Read More

[Kaiser Health News] ‘National Dialogue’ Urged On Cost Of New Hepatitis C Drug

May 28, 2014

“The outcry continues over the $1,000-a-pill hepatitis C drug made by Read More

[POLITICO Pulse] NEW COALITION TARGETS SOLVADI COST

May 28, 2014

“A broad coalition of health care groups is trying to compel the Read More

[POLITICO Pro] 80-group campaign targeting hepatitis drug cost

May 28, 2014

“More than 80 organizations are launching the Campaign for Sustainable Rx Read More

[CNBC] The $84,000 question: Will focusing on drug prices rein in costs?

May 22, 2014

By Meg Tirrell May 22, 2014   The mounting scrutiny of prescription drug Read More

[MedPage Today] Medicaid Directors Question Need for $1,000 HCV Pill

May 22, 2014

By Michael Smith May 22, 2014   The evidence base for one of the star Read More

[Healthcare Payer News] Sovaldi spurs call to action on high drug costs

May 21, 2014

By Anthony Brino May 21, 2014   The breakthrough hepatitis drug Sovaldi Read More

[Politico] No consensus on how to afford specialty drugs

May 21, 2014

By Brett Norman May 21, 2014 The astronomical price of a new “miracle” Read More

[Inside Health Policy] Spurred By Sovaldi’s Price, Drug Makers & Plans Consider Mortgaging Pricey Drugs

May 21, 2014

By John Wilkerson May 21, 2014   Spurred by the prospect of Sovaldi’s Read More

[Reuters] U.S. health insurers say Gilead hepatitis C drug too costly

May 21, 2014

By Bill Berkrot May 21, 2014   The leading U.S. health insurance trade Read More

[The Hill] Insurance lobby: Let’s beat government to drug cost reform

May 21, 2014

By Ferdous Al-Faruque May 21, 2014   The top health insurance lobbyist Read More

[Modern Healthcare] Excessive drug costs could invite price caps: AHIP’s Ignagni

May 21, 2014

By Paul Demko May 21, 2014   The steep cost of Sovaldi—Gilead Read More